Centers for Disease Control and Prevention

National Center for Immunization and Respiratory Diseases

Photographs and images included in this presentation are licensed solely for CDC/NCIRD online and presentation 

use. No rights are implied or extended for use in printing or any use by other CDC CIOs or any external audiences.

Implementation Update on 

2023–2024 COVID-19 Vaccines

Shannon Stokley, DrPH

Immunization Services Division

Centers for Disease Control and Prevention
Commercialization Transition
▪ The CDC COVID-19 Vaccination Program discontinued on:

– September 12, 2023, as applied to the bivalent Moderna and Pfizer-BioNTech 

COVID-19 vaccines

– October 3, 2023, as applied to the ancestral (Original) Novavax COVID-19 Vaccine

▪ Providers are encouraged to:

– Continue administering COVID-19 vaccine through their offices/pharmacies/other 

practices

– Participate in vaccines.gov

▪ Vaccine data reporting has transitioned to routine reporting processes for 

jurisdictions that have signed data use agreement (DUA) with CDC.

U.S. Government Vaccination Program Discontinuation
▪ Updated COVID-19 vaccines are available to most people living in the U.S. 

at no cost through their private health insurance, Medicare, and Medicaid 

plans.

Vaccine Cost/Insurance

*Adults with health insurance that does not cover all COVID-19 vaccine costs, at any Bridge Access Program site which is in-network for their health insurance.

Private health 

insurance

Plans that are ACAcompliant cover COVID19 vaccines from an innetwork provider at no 

cost-sharing.

Medicare and Medicaid

Cover COVID-19 

vaccines at no-cost 

sharing

Government programs

Provide vaccine at no cost for:

• VFC: Children through 18 years that 

are Medicaid eligible, uninsured, 

American Indian/Alaska Native, or 

underinsured

• Bridge Access Program: Adults ages 

18 years and older who are 

underinsured* or uninsured
▪ There is increasing supply of vaccine to meet demand.

– Moderna, Pfizer-BioNTech, and Novavax are available.

▪ CDC is continuing to have conversations with manufacturer and 

distributors to ensure timely distribution of COVID-19 vaccines.

▪ Visit vaccines.gov to find a COVID-19 vaccine near you.

Vaccine Availability
Bridge Access Program
▪ CDC’s Bridge Access Program provides no-cost COVID-19 vaccines to 

adults without health insurance and adults whose insurance does not 

cover all COVID-19 vaccination costs.

– All CDC-recommended COVID-19 vaccines are included in the Bridge Access 

Program.

– The Bridge Access Program will end by December 31, 2024.

– The Vaccines for Adults (VFA) program, proposed in the FY 2023 and 2024 

Presidential Budget, would be a long-term solution to ensure all adults have access 

to recommend vaccinations, including COVID-19 vaccines, at no cost to them.

CDC’s Bridge Access Program
Adults 18 years and older without health insurance

-andAdults with health insurance that does not cover all COVID-19 

vaccine costs (only at Bridge Access Program sites that are innetwork for their health insurance)

Who Can Get a No-Cost COVID-19 Vaccine Through the 

Bridge Program
Where to Get a No-Cost COVID-19 Vaccine through the 

Bridge Access Program? 

Visit Vaccines.gov to find a provider that offers no-cost COVID-19 

vaccines through the Bridge Access Program!

Community 

events or 

pop-up sites 

with these 

groups

Local Healthcare Providers

Retail Pharmacies:

Walgreens, CVS, eTrueNorth (pharmacy aggregator)

HRSA-Supported Centers
Bridge Program Ordering and Administration*

*Data as of 10/20/2023

There are >24,000 contracted pharmacy locations and

>380,000 doses have been administered by contracted 

pharmacies to individuals without insurance in the U.S.

Rx

>4,400 public health safety net providers have placed >6,100 

orders for >287,000 doses of COVID-19 vaccine using 317 funds. 

Nationally, 81% of people without insurance are estimated to be 

within a 5-mile drive distance to a Bridge Access Program provider.
Vaccination Coverage
Snapshot of COVID-19 vaccine data reporting plans

Administration data from reporting states National Immunization Surveys

Bridge Access Program for COVID-19 Vaccines

Other surveillance systems

Vaccine Safety Datalink

Other data sources

Omnibus surveys

Internet panel survey of pregnant people

Distribution data

National Healthcare 

Safety Network
Among 14,715 adults ages 18 years and older, 7.1% reported having 

received a COVID-19 vaccine since September 14, 2023.

COVID-19 Vaccination Status and Intent Among Adults Age ≥18 Years by Demographics, 

National Immunization Survey-Adult COVID Module, October 8–14, 2023

Probably or definitely will NOT get vaccinated

Up to date with 2023-24 COVID-19 vaccine

Definitely will get vaccinated

Probably will get vaccinated or unsure

0.8

8.1

10.2

3.5

7.6

8.3

4.6

4.9

7.0

8.2

2.3

2.6

4.7

7.5

15.4

20.5

6.5

7.7

7.1

31.2

15.1

23.2

19.3

23.9

27.2

24.4

22.9

24.5

25.5

16.5

20.3

23.9

28.7

30.8

36.2

22.3

27.0

24.6

21.5

35.2

27.9

46.1

39.6

23.1

51.9

26.5

30.7

32.0

35.7

33.0

35.4

26.0

26.0

25.9

30.9

30.4

30.6

46.5

41.6

38.7

31.2

28.9

41.4

19.1

45.7

37.8

34.3

45.5

44.1

35.9

37.8

27.7

17.4

40.3

34.9

37.6

0 25 50 75 100

AI/AN

Multi/Other

NH/OPI**

Hispanic

Black

White

Asian

Rural

Suburban

Urban

18-29

30-39

40-49

50-64

65-74

75+

Male

Female

Overall

Weighted %

12.5

7.0

4.7

7.2

7.1

4.0

5.8

9.0

1.7

7.8

31.1

24.6

35.2

24.5

18.8

18.4

24.9

30.2

15.2

26.2

35.2

30.4

31.2

29.4

34.2

44.5

31.3

23.9

44.0

28.9

21.2

38.0

28.9

38.8

39.9

33.1

38.1

36.8

39.1

37.1

0 25 50 75 100

Transgender/Nonbinary

Cisgender

Gay/Lesbian/Bisexual/Other

Straight

Income unknown

Below poverty

Above poverty, <$75k

Above poverty, ≥$75k

Not insured

Insured

Weighted %
Receipt of a COVID-19 vaccine was more frequently reported among 

adults who were older, insured, and with higher incomes.

COVID-19 Vaccination Status and Intent Among Adults Age ≥18 Years by Demographics, 

National Immunization Survey-Adult COVID Module, October 8–14, 2023

Probably or definitely will NOT get vaccinated

Up to date with 2023-24 COVID-19 vaccine

Definitely will get vaccinated

Probably will get vaccinated or unsure

0.8

8.1

10.2

3.5

7.6

8.3

4.6

4.9

7.0

8.2

2.3

2.6

4.7

7.5

15.4

20.5

6.5

7.7

7.1

31.2

15.1

23.2

19.3

23.9

27.2

24.4

22.9

24.5

25.5

16.5

20.3

23.9

28.7

30.8

36.2

22.3

27.0

24.6

21.5

35.2

27.9

46.1

39.6

23.1

51.9

26.5

30.7

32.0

35.7

33.0

35.4

26.0

26.0

25.9

30.9

30.4

30.6

46.5

41.6

38.7

31.2

28.9

41.4

19.1

45.7

37.8

34.3

45.5

44.1

35.9

37.8

27.7

17.4

40.3

34.9

37.6

0 25 50 75 100

AI/AN

Multi/Other

NH/OPI**

Hispanic

Black

White

Asian

Rural

Suburban

Urban

18-29

30-39

40-49

50-64

65-74

75+

Male

Female

Overall

Weighted %

12.5

7.0

4.7

7.2

7.1

4.0

5.8

9.0

1.7

7.8

31.1

24.6

35.2

24.5

18.8

18.4

24.9

30.2

15.2

26.2

35.2

30.4

31.2

29.4

34.2

44.5

31.3

23.9

44.0

28.9

21.2

38.0

28.9

38.8

39.9

33.1

38.1

36.8

39.1

37.1

0 25 50 75 100

Transgender/Nonbinary

Cisgender

Gay/Lesbian/Bisexual/Other

Straight

Income unknown

Below poverty

Above poverty, <$75k

Above poverty, ≥$75k

Not insured

Insured

Weighted %
2.1

2.7

2.7

0.7

2.2

2.4

1.4

2.1

0 2 4 6 8 10

Other/multiple races, non-Hispanic

Black, non-Hispanic

White, non-Hispanic

Hispanic

12-17 years

5-11 years

6 months-4 years

All children

Percent

2.1% of children were reported to have received the updated 2023-24 

COVID-19 vaccination since it was recommended on September 14th, 

2023. 2023-24 COVID-19 Vaccination Coverage, 

Children Ages 6 Months-17 Years, National Immunization Survey-Child Covid Module (NIS-CCM)

Interviews week of: 10/8/2023 - 10/14/2023 (n=2,767)

3.1

0.8

1.5

2.7

1.4

0.9

2.8

0.8

3.1

0 2 4 6 8 10

Uninsured

Other insurance

Any Medicaid

Rural

Suburban

Urban

Unknown income

Below poverty

Above poverty, <$75,000/year

Above poverty, >=$75,000/year

Percent
Parents’ intent to get their child vaccinated was mixed.

Percentages vaccinated are all <3% and do not show well on this slide, please see previous slide.

2023-24 COVID-19 Vaccination Coverage and Parental Intent, 

Children Ages 6 Months-17 Years, National Immunization Survey-Child Covid Module (NIS-CCM)

Interviews week of: 10/8/2023 - 10/14/2023 (n=2,767)

25.4

30.5

25.3

26.5

29.2

25.8

23.2

26.4

41.9

39.9

27.4

40.1

36.6

30.9

34.7

33.8

30.6

26.9

44.6

32.7

32.0

40.9

40.7

37.7

0 20 40 60 80 100

Other/multiple races, non-Hispanic

Black, non-Hispanic

White, non-Hispanic

Hispanic

12-17 years

5-11 years

6 months-4 years

All children

Percent

23.7

28.0

25.2

19.5

24.8

31.7

20.0

23.5

22.4

32.5

33.0

32.9

33.0

20.2

34.9

37.6

41.9

30.4

33.4

31.2

43.3

36.0

40.9

58.8

37.6

29.4

37.3

43.4

43.4

33.2

0 20 40 60 80 100

Uninsured

Other insurance

Any Medicaid

Rural

Suburban

Urban

Unknown income

Below poverty

Above poverty, <$75,000/year

Above poverty, >=$75,000/year

Percent
▪ NIS data collected October 8-14, 2023 provides estimates about four weeks since the 

September 14, 2023 rollout of the 2023-24 COVID-19 vaccine

▪ Children (6 months–17 years)

– 2.1% (95% CI: 1.1-3.0) of children had received the updated 2023-24 COVID-19 vaccine 

– Slightly more than a quarter of children (33.8%, 95% CI: 30.6-37.1) have a parent who said they 

definitely will get their child vaccinated while 2 in 5 children (37.7%, 95% CI: 34.4-41.0) have a parent 

that said they probably or definitely will not get their child vaccinated

▪ Adults (≥18 years)

– 7.1% (95% CI: 6.3-8.0) of adults had received the updated 2023-24 COVID-19 vaccine

– 24.6% (95% CI: 23.0-26.2) of adults said they definitely will get vaccinated, and 37.6% (95% CI: 35.7-

39.5) said they probably or definitely will not get vaccinated

COVID Vaccination Coverage Summary
For more information, contact CDC

1-800-CDC-INFO (232-4636)

TTY: 1-888-232-6348 www.cdc.gov

The findings and conclusions in this report are those of the authors and do not necessarily represent the official 

position of the Centers for Disease Control and Prevention.

Photographs and images included in this presentation are licensed solely for CDC/NCIRD online and presentation 

use. No rights are implied or extended for use in printing or any use by other CDC CIOs or any external audiences.